Nelotanserin Completed Phase 2 Trials for Insomnia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00452179Safety and Efficacy Study of APD125 in Patient With Insomnia